m.silva
TL2 · Bursa
Contributes reviews on supplier material. Based in Bursa.
Joined 23 June 2025 · last posted 16d
74 posts, newest first. Showing up to 150.
-
Seven-day rolling means and why weekly readings mislead Replied, post #18 · Outcomes › Progress reports · 12 Jul 2026 · 8 likes I read post #16 twice before replying, because I had assumed the opposite. Day-to-day body mass varies by more than a kilogram on hydration, glycogen and gut contents…
-
Revisiting: Protein density versus volume when you cannot eat much Replied, post #55 · Nutrition & Training › Protein & intake · 12 Jul 2026 · 0 likes I have been on both sides of the Protein density versus volume argument in this category within eighteen months, which should tell you how strong the evidence for…
-
Aggregate verification data across the directory, with caveats Replied, post #5 · Sourcing › Independent verification · 19 Jun 2026 · 18 likes A record with four results over sixteen months is a thin record rather than a bad one, and the honest description says which.
-
Revisiting: Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #46 · Evidence › Journal club · 19 Jun 2026 · 0 likes The baseline characteristics table is the single most useful page for the questions that get asked here, because it tells you who the result applies to.
-
Coming back to: Why I now write the concentration on the vial in marker Replied, post #8 · Practice › Reconstitution · 31 May 2026 · 1 like Choose the concentration so that a typical dose lands on a graduation you can actually read. A dose that falls between two marks on a 1 mL barrel is a dose you will get…
-
Why the timeline is on the right and not the left — what changed since Replied, post #45 · Meta › Site feedback · 30 May 2026 · 0 likes Clear enough that I do not think I have a follow-up, which is unusual.
-
Official shortage notices and what they authorise Replied, post #54 · Access › Shortages · 17 May 2026 · 3 likes I would call the community position on official shortage notices likely rather than established, and I would be comfortable defending that hedge.
-
[2026 update] Regional warehouse stock versus direct despatch Replied, post #68 · Sourcing › Logistics · 12 May 2026 · 0 likes I will take the caveat as seriously as the claim, which is the point of putting it there.
-
Revisiting: Primary endpoint hierarchies and why order matters Replied, post #5 · Evidence › Trials · 5 May 2026 · 17 likes Post #4 is the version of this I will quote in future. One addition. I would call the community position on Primary endpoint hierarchies likely rather than established,…
-
Reading a home test result without over-claiming Replied, post #26 · Analytics › Home & field testing · 29 Apr 2026 · 1 like Anything that changes colour is measuring a reaction, and reactions have interferents. A positive result in the presence of an excipient you did not expect is not…
-
Converting between mg/mL and units per dose, both directions — the long version Replied, post #90 · Practice › Reconstitution · 23 Apr 2026 · 20 likes Taking post #87 at face value and following it one step further. Preservative effectiveness is tested against a defined microbial challenge under defined conditions. It…
-
Journal club: is percentage weight change the right endpoint? Replied, post #78 · Evidence › Journal club · 18 Apr 2026 · 15 likes Where I part company with post #75, and it is a narrow parting. Sessions on negative or null results are consistently the most instructive and the hardest to get anyone…
-
Why this subcategory is stricter about sourcing than most Replied, post #17 · Compounds › Secretagogues & GH axis · 11 Apr 2026 · 11 likes Everything in post #15 holds. The case it does not cover is the one I have. Effects reported at the level of appetite are the most consistently described and the most…
-
The 2.5 mg starting dose is not a therapeutic dose — why that matters Replied, post #75 · Compounds › Tirzepatide · 8 Apr 2026 · 18 likes What I can speak to on 2.5 mg starting dose is narrow, so I will keep it narrow rather than generalising from it. Beyond that boundary I do not know.
-
Adducts: sodium, potassium, and the peak you did not expect — does this still hold? Replied, post #96 · Analytics › Mass spectrometry · 5 Apr 2026 · 11 likes This follows post #95 rather than contradicting it. Resolution: "high resolution" commonly means I would rather be precise about what I do not know than vague about…
-
Second pass at: How to ask a question when you cannot say why you are asking it Replied, post #81 · Start Here › How to Ask · 3 Apr 2026 · 32 likes Questions you cannot explain: "I cannot say why I am asking this, but is this compound stable at room temperature?" is more productive than no question at all. People…
-
GLP-1 receptor distribution: central and peripheral Replied, post #23 · Pharmacology › Receptor biology · 29 Mar 2026 · 5 likes The area postrema sits outside the blood-brain barrier and is where a great deal of the nausea signalling in this class originates. That is why the effect is central…
-
Solubility limits and what a cloudy solution is telling you Replied, post #6 · Pharmacology › Formulation chemistry · 28 Mar 2026 · 13 likes Isotonicity: an isotonic solution has the same osmotic pressure as blood. Non-isotonic solutions can cause discomfort on injection. Injectable peptide solutions are…
-
Lean mass preservation: what the evidence supports — does this still hold? Replied, post #48 · Outcomes › Body composition · 27 Mar 2026 · 1 like Nothing to add, except that this is the answer I would give if asked.
-
Coming back to: Solubility limits and what a cloudy solution is telling you Replied, post #8 · Pharmacology › Formulation chemistry · 13 Mar 2026 · 33 likes This is the first time the answer has come with its own limits attached. Appreciated.
-
Revisiting: Maintainer handover: how it works Replied, post #43 · Meta › Wiki maintenance · 10 Mar 2026 · 15 likes The documentation on Maintainer handover is better than this thread and I say that as someone who has posted in the thread.
-
Contributing data without breaching anyone's privacy Replied, post #39 · Data & Tools › Datasets · 5 Mar 2026 · 22 likes Post #36 is the version of this I will quote in future. One addition. Independent test results are the most valuable data this community collects, and they are only…
-
Second pass at: The topic list is dense — is that deliberate? Replied, post #79 · Meta › Site feedback · 22 Feb 2026 · 3 likes Confirming post #76 from a second method, which matters more than confirming it from a second person. Practical note on topic list: write down what you expect before…
-
Revisiting: A page that has drifted out of date and needs a maintainer Replied, post #37 · Documentation › Wiki requests · 14 Jan 2026 · 16 likes Translation suggestions: if a maintained page should exist in another language, suggesting it here helps the maintainers prioritise multilingual work. It is worth…
-
[2026 update] Does a peptide degrade silently, with no visual change? Replied, post #13 · Practice › Storage & stability · 13 Jan 2026 · 25 likes Useful. I have added it to my own notes with the date on it.
-
Stepping down deliberately, and how to do it without losing progress Replied, post #38 · Practice › Dosing & titration · 6 Jan 2026 · 2 likes Where I part company with post #37, and it is a narrow parting. Concentration and dose get conflated constantly in this subcategory. Changing how much diluent you add…
-
Second pass at: What "verified" means on our vendor pages, stated narrowly Replied, post #40 · Sourcing › Vendor reports · 29 Nov 2025 · 29 likes Worth separating two things that post #36 runs together. The cost of a submission is worth stating. It is the main reason people do not do this and knowing the figure…
-
Prescription requirements and telehealth models Replied, post #38 · Sourcing › Regulatory · 29 Nov 2025 · 0 likes On prescription requirements and telehealth models the community has more anecdote than the confidence in this thread implies, and I include my own contribution in that.
-
Realistic expectations for strength while losing weight quickly Replied, post #39 · Nutrition & Training › Resistance training · 25 Nov 2025 · 0 likes Cardiovascular work has its own benefits and is not a substitute for a resistance stimulus for this particular purpose.
-
A history of disordered eating: proceeding carefully Replied, post #9 · Wellbeing › Mental health · 21 Nov 2025 · 0 likes Everything in post #6 holds. The case it does not cover is the one I have. Maintenance brings a different set of psychological questions from loss, and the discussion…
-
The anatomy of a question that gets answered within an hour — the long version Replied, post #116 · Start Here › How to Ask · 19 Nov 2025 · 2 likes Questions you cannot explain: "I cannot say why I am asking this, but is this compound stable at room temperature?" is more productive than no question at all. People…
-
Documentation that appears only after payment Replied, post #80 · Sourcing › Red flags · 18 Nov 2025 · 14 likes The guidelines draw that line for a practical reason as much as a fair one: reports accumulate into something useful and allegations do not. I would rather post the…
-
[2026 update] What steady state means for the decision to escalate Replied, post #118 · Practice › Dosing & titration · 17 Nov 2025 · 1 like Two things can be true about steady state at once: the mechanism is plausible and the evidence for the size of the effect is thin. Most of the argument here is people…
-
Pen dose counters: what a click does and does not guarantee Replied, post #69 · Devices › Pens & autoinjectors · 17 Nov 2025 · 0 likes Off-label dosing with a pen: if you want to deliver a dose different from the pen's pre-set steps (e.g., halfway between two step doses), that is off-label use. Some…
-
Lurking for two months before posting: was that the right call? Replied, post #3 · Start Here › Welcome · 16 Nov 2025 · 0 likes Thank you for taking the time. That was more work than a reply usually is.
-
EMA product information as a primary source Replied, post #56 · Regional › European Union · 11 Nov 2025 · 0 likes EMA product information: I have looked for the primary source twice and failed twice. Either it does not exist or it is somewhere I do not know to look, and I would…
-
Coming back to: Feature request: should a dose-equivalence tool exist at all? Started this topic · Data & Tools › Calculators · 3 Nov 2025 · 15 likes Feature request: should a dose-equivalence tool exist at all? I have a specific reason for asking rather than idle curiosity, and the context is below. Reading back…
-
Payment mechanics and the recovery options that do not exist Replied, post #20 · Sourcing › Payments · 19 Oct 2025 · 15 likes Two claims get bundled together under payment mechanics and they need separating. The descriptive one — this is what was observed — is usually well supported. The…
-
The nausea timeline across the first four weeks, with a tabulated log Replied, post #102 · Practice › Side effects · 29 Sep 2025 · 24 likes A note on scope: what I am saying about nausea timeline applies to the case in the first post and I would not extend it further without checking.
-
Semaglutide versus liraglutide head to head: reading STEP 8 carefully Replied, post #64 · Compounds › Semaglutide · 25 Sep 2025 · 0 likes Good question, well framed, and I would like to see it answered properly.
-
Titles that describe the question, not the situation Replied, post #104 · Start Here › How to Ask · 24 Sep 2025 · 21 likes Quantities without units are the single commonest reason a question sits unanswered. "Two and a half" is not a dose, a volume or a concentration until you say which.…
-
Reading SURMOUNT-1 without the press release Replied, post #12 · Compounds › Tirzepatide · 19 Sep 2025 · 1 like Categorical response thresholds — the proportion reaching ten, fifteen or twenty per cent reduction — are more persuasive and less informative than the mean. They…
-
"Should I double up?" — answered once, at length, calmly Replied, post #16 · Practice › Administration · 5 Sep 2025 · 12 likes I read post #15 twice before replying, because I had assumed the opposite. If you have to inject at a different time of day than usual, that is a much smaller…
-
Revisiting: Review: an evidence digest and the citation check that delayed it Replied, post #8 · Documentation › Doc review · 22 Aug 2025 · 0 likes Building on post #7 rather than restating it. Where the review finds the content is right but the framing overstates it, that is the most valuable catch available at…
-
Second pass at: Why this subcategory is stricter about sourcing than most Replied, post #81 · Compounds › Secretagogues & GH axis · 20 Aug 2025 · 24 likes Good question, well framed, and I would like to see it answered properly.
-
Power cut for eleven hours: how I assessed it afterwards Replied, post #17 · Practice › Storage & stability · 8 Aug 2025 · 0 likes Quietly grateful for the plain phrasing. Not every thread gets that.
-
Revisiting: Completing a dose with a second syringe, and the dead-volume arithmetic Replied, post #16 · Practice › Administration · 19 Jun 2025 · 0 likes Post #13 and I disagree about the size of the effect, not about the direction. A site rotation scheme that actually works: abdomen, outer thigh, back of arm, outer hip.…
-
An appeal that failed, and what I would do differently Replied, post #5 · Access › Insurance & coverage · 8 Jun 2025 · 4 likes Documentation your clinician can provide: letters from clinicians describing why standard treatments have failed or are contraindicated are often exactly what an…
-
Domestic fridge temperature mapping: a cheap experiment — what changed since Replied, post #113 · Devices › Cold chain · 30 May 2025 · 17 likes Domestic fridge temperature mapping came up in a thread eighteen months ago and was answered well. I cannot find it, which is itself the problem, so here is the…
-
Lean mass preservation: what the evidence supports Replied, post #5 · Outcomes › Body composition · 6 May 2025 · 25 likes Precision versus accuracy: the precision you need depends on what question you are answering. "Am I losing fat?" requires less precision than "Is my lean mass…
-
Specificity, linearity, accuracy, precision, range, robustness — with real criteria — a… Started this topic · Analytics › Method validation · 25 Apr 2025 · 4 likes On the subject in the title: Specificity, linearity, accuracy, precision, range, robustness — with real criteria — a second dataset Working notes rather than a…
-
Particulates in a reconstituted solution: identifying the likely source — what changed… Replied, post #2 · Analytics › Impurities & related substances · 19 Apr 2025 · 22 likes Nothing to add on the substance. Thank you for taking the question at face value.
-
Follow-up: How much fluid is actually needed, and how you would know Replied, post #4 · Nutrition & Training › Hydration & electrolytes · 4 Apr 2025 · 26 likes Cramping is the symptom most confidently attributed to electrolytes and has the weakest evidence linking it to them. The answer changed when I changed how I was…
-
Criticising the method without criticising the authors Replied, post #52 · Evidence › Study critique · 1 Apr 2025 · 6 likes I read post #49 twice before replying, because I had assumed the opposite. Surrogate endpoints are not automatically bad and their validity is compound-specific and…
-
Reading order for a first week here, and what to skip until later Replied, post #44 · Start Here › Welcome · 20 Mar 2025 · 0 likes On the reading order question specifically: start with the how-to-ask materials in this category, then read the one to three subcategories where your main questions…
-
Albumin binding and how it produces a long half-life Replied, post #15 · Pharmacology › Pharmacokinetics · 17 Mar 2025 · 0 likes Confirming post #12 from a second method, which matters more than confirming it from a second person. Small correction to my own earlier position on albumin binding. I…
-
Adjudicated events and why the definition matters — the long version Replied, post #40 · Evidence › Trials · 9 Mar 2025 · 3 likes Dropout is information: high dropout rates can indicate tolerability problems or lower efficacy than the summary suggests. Where the analysis handled dropouts matters.…
-
Assessing a warm arrival: the decision process Replied, post #10 · Sourcing › Logistics · 6 Mar 2025 · 0 likes On post #6 — agreed on the reasoning, with one qualification. Photographing the parcel on arrival before opening it takes ten seconds and is the difference between a…
-
Pharmaceutical compounding rules, summarised from primary sources Replied, post #70 · Sourcing › Regulatory · 2 Mar 2025 · 0 likes Practical answer on pharmaceutical compounding rules, since the theoretical one is upthread: do the simplest check first, write down the result, and only then decide…
-
About the Journal club category Replied, post #4 · Evidence › Journal club · 7 Feb 2025 · 0 likes Suggestion for the wiki post above: it would be worth linking the two or three most-referenced topics in this category directly, since new members reliably ask for…
-
Second pass at: Cross-border purchase within the EU: the actual rules Replied, post #24 · Access › International · 2 Feb 2025 · 2 likes Import rules for personal use: what you can import for personal use depends on your country's rules, not on where it is sold. Checking your country's rules before…
-
What we do not know about retatrutide, listed explicitly Replied, post #50 · Compounds › Retatrutide · 10 Jan 2025 · 0 likes Nausea and vomiting were dose-related in the phase 2 work, as they are throughout this class. What is not established is whether the tolerability profile differs from…
-
Body image changing more slowly than the body Replied, post #97 · Wellbeing › Mental health · 22 Dec 2024 · 16 likes Adding what did not work for me on body image, since the failures never get written up and they are half the useful information.
-
Injection-site reactions: describing them precisely enough to be useful Replied, post #72 · Practice › Side effects · 14 Dec 2024 · 0 likes On injection-site reactions the community has more anecdote than the confidence in this thread implies, and I include my own contribution in that.
-
[2026 update] New subcategory: rationale and scope Replied, post #58 · Meta › Announcements · 11 Dec 2024 · 15 likes Notifications: watching this subcategory means you receive notifications when announcements are posted. Useful if you want to stay current.
-
[2026 update] Step therapy requirements and how to satisfy them Replied, post #40 · Access › Insurance & coverage · 24 Nov 2024 · 3 likes Distinguishing three things in the Step therapy requirements discussion that keep getting used interchangeably: the observation, the proposed mechanism, and the…
-
Converting between mg/mL and units per dose, both directions Replied, post #75 · Practice › Reconstitution · 3 Nov 2024 · 9 likes Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and neither helps a peptide go into solution any faster than patience does.
-
When to suspect the method rather than the sample Replied, post #29 · Analytics › Method validation · 28 Oct 2024 · 4 likes Adding thanks rather than a view. I do not have a view worth the space.
-
Follow-up: What this community means by "a source", in practical terms Replied, post #7 · Start Here › Welcome · 22 Sep 2024 · 29 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
-
Tracking a preprint to publication: a worked example — the long version Replied, post #31 · Evidence › Preprints · 28 Aug 2024 · 13 likes Everything in post #27 holds. The case it does not cover is the one I have. Peer review catches some things reliably — missing methods, unsupported conclusions,…
-
A rising related-substance total over six months: degradation or method drift? Replied, post #11 · Analytics › Impurities & related substances · 27 Aug 2024 · 1 like The thing about rising related-substance that took me longest to accept is that a plausible mechanism is not evidence of an effect. It is a reason to look, not a result.
-
Naming conventions for research peptides and the confusion they cause — one year on Replied, post #4 · Compounds › Other compounds · 23 Jul 2024 · 16 likes Taking post #3 at face value and following it one step further. Distinguishing marketed research compounds from true chemical synthesis: some online suppliers sell…
-
Journal club: FLOW and the renal composite, component by component Replied, post #60 · Evidence › Journal club · 15 Jul 2024 · 14 likes Adding the measurement that post #56 says would settle it. The baseline characteristics table is the single most useful page for the questions that get asked here,…
-
Where the four-week escalation interval comes from, and what it is not Replied, post #23 · Practice › Dosing & titration · 17 Jun 2024 · 0 likes Narrowing post #20, because the general version has more than one answer. Four-week escalation interval looks different depending on whether you are reading the primary…